[10] Low NAD+ levels have recently been associated with a variety of age-related ailments and diseases linked to increased oxidative/free radical damage, including diabetes, heart disease, vascular dysfunction, ischemic brain injury, Alzheimers disease, and vision loss
Studies on tendon fibroblasts also indicated changes in the expression of receptors and proteins associated with the cellular response, which allows BPC-157 20 mg PEN to be presented as a research peptide for analyses of cell signalling and remodelling of extracellular structures
Both have been studied in overlapping contexts (fibroblast proliferation in cited models, tendon repair, muscle injury), but through different enough mechanisms that combination research is scientifically justified
To receive the maximal benefits from BPC-157 it is recommended to take for 12 weeks, with a one month break, then treatment can be restarted
This guide walks through the real differences, where each shines on its own, and why combining them has become the default
BPC-157 also activates growth hormone receptors specifically in tendon and ligament tissue, which is why its effects on musculoskeletal injuries are more pronounced than those of many other anti-inflammatory approaches